2h
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...
Congenital factor VII deficiency is a rare, autosomal recessive disorder with an estimated prevalence of 1 in 1,000,000. We ...
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback